Spaceflight-associated neuro-ocular syndrome a potential challenge during long missions.
Advances in treatment and surgical techniques have transformed patient care.
Constance O. Okeke, MD, shared insights from on her presentation entitled, "Reduction in IOP after switching to latanoprostene bunod in glaucoma patients in real-world clinical practice," which was given at the American Academy of Ophthalmology held in Chicago, Illinois.
This research was a finalist in the 2020 Ophthalmology Times® Research Scholar Honoree Program.
Physicians can discover, diagnose, document, treat diseases that might go undetected
For health care workers, the pandemic has led to increased burnout, concerns about workplace safety, and staffing shortages that threaten not only patient care but also the entire provider ecosystem.
Cyclosporine superior to vehicle, improves corneal staining in dry eye disease
Answers to common questions that can help kick-start the journey into the metaverse to learn from the many virtual educational meetings and conference opportunities while mingling with colleagues worldwide.
Dr. London discusses a case of diabetic macular edema (DME) with persistent subretinal fluid, emphasizing the diagnostic considerations, treatment options, and the implications for patient outcomes in the context of evolving therapeutic approaches.
First new therapy in nearly a decade offers another option for physicians, patients
Current Fuchs endothelial corneal dystrophy treatments include implanted cultured human endothelial cells.
Future investigations will assess findings, evaluate their prognostic value.
The project, presented by Colton Hill, MPH, on behalf of the Dean McGee Eye Institute, looks at complication rates during cataract surgery or after cataract surgery for patients with prior intravitreal injections or incisional retinal procedures.
An expert weighs in on considerations involved in the choice between multifocal and light adjustable lenses.
Shifting the treatment paradigm can lead to less pain and inflammation.
The key to successful management of oGVHD is early diagnosis
Physician outlines the latest emerging technologies to treat the condition.
Optics block out-of-focus and stray light, allow continuum of vision.
Unique clinical trials and novel products of interest currently under investigation for the treatment of dry eye disease.
Representatives from Magellan Rx Management provided a detailed overview of current treatment options in ophthalmology and the impact that biosimilars could have.
Physicians can use navigational tools to attain a much more immersive perspective.
Sunil Srivastava, MD, shares his experience using dexamethasone and fluocinolone acetonide implants to manage chronic non-infectious uveitis.
Lens thickness and anterior chamber duct values obtained by Lenstar can be improved by SpikeFinder to reduce errors in measurements.
Papilledema with back pain suggests spine lesion.